Abstract
A patient who developed significant metabolic acidosis and severe hyperkalaemia while taking Moduretic (amiloride and hydrochlorothiazide) is reported. During the period of hyperkalaemia (maximum potassium 7-6 mmol/l) the patient's whole body potassium content was normal. His acid-base balance and serum potassium returned to normal some 10 days after stopping the drug. The possible mechanism of acidosis and hyperkalaemia in this patient is discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gabow P. A., Moore S., Schrier R. W. Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med. 1979 Mar;90(3):338–340. doi: 10.7326/0003-4819-90-3-338. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Koch-Weser J. Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. JAMA. 1973 Jul 2;225(1):40–43. doi: 10.1001/jama.225.1.40. [DOI] [PubMed] [Google Scholar]
- Neale T. J., Lynn K. L., Bailey R. R. Spironolactone-associated aggravation of renal functional impairment. N Z Med J. 1976 Mar 10;83(559):147–149. [PubMed] [Google Scholar]
- Norby L. H., Weidig J., Ramwell P., Slotkoff L., Flamenbaum W. Possible role for impaired renal prostaglandin production in pathogenesis of hyporeninaemic hypoaldosteronism. Lancet. 1978 Nov 25;2(8100):1118–1122. doi: 10.1016/s0140-6736(78)92275-4. [DOI] [PubMed] [Google Scholar]
- Tannen R. L. Relationship of renal ammonia production and potassium homeostasis. Kidney Int. 1977 Jun;11(6):453–465. doi: 10.1038/ki.1977.63. [DOI] [PubMed] [Google Scholar]